Guangxi Kainan Biotechnology Co., Ltd. · 66-41 · CHINA
For Guangxi Kainan Biotechnology Co., Ltd., import alert is 66-41; country is CHINA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Supplements/Capsules | Supplements/Capsules; product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 07/22/2025; address is Unknown , Unknown, CHINA, verified against its source on 2026-10-01.
- Firm
- Guangxi Kainan Biotechnology Co., Ltd. verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CHINA verified
- Address
- Unknown , Unknown, CHINA verified
- Date published
- 07/22/2025 verified
- Product code
- 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Supplements/Capsules | Supplements/Capsules each item verified
What the source says
Guangxi Kainan Biotechnology Co., Ltd. Date Published : 07/22/2025 Unknown , Unknown, CHINA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code and Product
54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 07/22/2025 Desc: Supplements/Capsules Notes: 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 07/22/2025 Desc: Supplements/Capsules Notes:
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.